[H] [C@] 1(O[C@@] (C[C@H] (O) [C@H] 1NC(C) =O) (O[C@H] 1[C@@H] (O) [C@@H] (CO) O[C@@H] (O[C@H] 2[C@H] (O) [C@@H] (NC(C) =O) [C@@H] (O[C@@H] 2CO) O[C@H] 2[C@@H] (O) [C@@H] (CO) O[C@@H] (O[C@H] 3[C@H] (O) [C@@H] (O) [C@H] (OC[C@H] (NC([*] ) =O) [C@H] (O) \C=C\CCCCCCCCCCCCC) O[C@@H] 3CO) [C@@H] 2O) [C@@H] 1O) C(O) =O) [C@H] (O) [C@H] (O) CO |
|
Mus musculus
(NCBI:txid10090)
|
Source: BioModels - MODEL1507180067
See:
PubMed
|
Homo sapiens
(NCBI:txid9606)
|
See:
DOI
|
View more via ChEBI Ontology
Outgoing
|
α- Neup5NAc- (2→3)- β- D- Galp- (1→4)- β- D- GlcpNAc- (1→3)- β- D- Galp- (1→4)- β- D- Glcp- (1↔1')- Cer
(CHEBI:36528)
has part
α-N-acetylneuraminyl-(2→3)-D-galactosyl group
(CHEBI:75127)
α- Neup5NAc- (2→3)- β- D- Galp- (1→4)- β- D- GlcpNAc- (1→3)- β- D- Galp- (1→4)- β- D- Glcp- (1↔1')- Cer
(CHEBI:36528)
has role
human metabolite
(CHEBI:77746)
α- Neup5NAc- (2→3)- β- D- Galp- (1→4)- β- D- GlcpNAc- (1→3)- β- D- Galp- (1→4)- β- D- Glcp- (1↔1')- Cer
(CHEBI:36528)
has role
mouse metabolite
(CHEBI:75771)
α- Neup5NAc- (2→3)- β- D- Galp- (1→4)- β- D- GlcpNAc- (1→3)- β- D- Galp- (1→4)- β- D- Glcp- (1↔1')- Cer
(CHEBI:36528)
is a
sialotetraosylceramide
(CHEBI:36543)
α- Neup5NAc- (2→3)- β- D- Galp- (1→4)- β- D- GlcpNAc- (1→3)- β- D- Galp- (1→4)- β- D- Glcp- (1↔1')- Cer
(CHEBI:36528)
is conjugate acid of
α-N-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosylceramide(1−)
(CHEBI:58665)
|
|
Incoming
|
α-N-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosylceramide(1−)
(CHEBI:58665)
is conjugate base of
α- Neup5NAc- (2→3)- β- D- Galp- (1→4)- β- D- GlcpNAc- (1→3)- β- D- Galp- (1→4)- β- D- Glcp- (1↔1')- Cer
(CHEBI:36528)
|
(2S,3R,4E)- 2- acylamino- 3- hydroxyoctadec- 4- en- 1- yl 5- acetamido- 3,5- dideoxy- D- glycero- α- D- galacto- non- 2- ulopyranonosyl- (2→3)- β- D- galactopyranosyl- (1→4)- 2- acetamido- 2- deoxy- β- D- galactopyranosyl- (1→3)- β- D- galactopyranosyl- (1→4)- β- D- glucopyranoside
|
(Gal)2 (Glc)1 (GlcNAc)1 (Neu5Ac)1 (Cer)1
|
KEGG GLYCAN
|
3'-LM1
|
KEGG GLYCAN
|
α- N- acetylneuraminosyl- (2→3)- β- D- galactosyl- (1→4)- N- acetyl- β- D- glucosaminyl- (1→3)- β- D- galactosyl- (1→4)- β- D- glucosylceramide
|
ChEBI
|
α- N- acetylneuraminosyl- (2→3)- β- D- galactosyl- (1→4)- N- acetyl- β- D- glucosaminyl- (1→3)- β- D- galactosyl- (1→4)- β- D- glucosylceramides
|
ChEBI
|
alpha- N- Acetylneuraminyl- 2,3- beta- D- galactosyl- 1,4- N- acetyl- beta- D- glucosaminyl- 1,3- beta- D- galactosyl- 1,4- D- glucosylceramide
|
KEGG COMPOUND
|
alpha- N- Acetylneuraminyl- 2,3- beta- D- galactosyl- 1,4- N- acetyl- beta- D- glucosaminyl- 1,3- beta- D- galactosyl- 1,4- D- glucosylceramide
|
KEGG COMPOUND
|
α- Neu5NAc- (2→3)- β- D- Gal- (1→4)- β- D- GlcNAc- (1→3)- β- D- Gal- (1→4)- β- D- Glc- (1↔1')- Cer
|
ChEBI
|
IV3-a-Neu5Ac-nLc4Cer
|
KEGG GLYCAN
|
IV3NeuAcα-nLc4Cer
|
ChEBI
|
IV3NeuAcnLcOSe4Cer
|
ChEBI
|
LM1
|
ChEBI
|
Neu5Ac(α2-3)Gal(β1-4)GlcNAc(β1-3)Gal(β1-4)Glc(β1-1)Cer
|
ChEBI
|
Neu5Ac-alpha2->3Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer
|
KEGG COMPOUND
|
Neu5Acα2-3Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ1-1Cer
|
ChEBI
|
sialosylneolactotetraosylceramide
|
ChEBI
|
Sialyl-3-paragloboside
|
KEGG GLYCAN
|
sialylparagloboside
|
ChEBI
|
snLc4Cer
|
KEGG GLYCAN
|
SPG
|
ChEBI
|
|